BCL2 and gastric cancer: Wu et al., 2014 found that Luteolin caused a decrement in the Bcl-2, antiapoptotic protein level by upregulating the tumor-suppressor miR-34a expression in gastric cancer cells; thus, for the first time, they revealed that miR-34a pathway held an important place in the Luteolin-induced apoptosis in gastric cancer cells [92].